Nicole Gormley, Former Division Director at FDA, shared a post on LinkedIn:
“A few weeks ago, I shared that I was leaving the Agency after more than a decade.
Today, I’m excited to share what comes next.
I’ve launched Gormley Advisory LLC – an independent regulatory consulting practice focused on oncology drug development.
The work I’m most proud of at the FDA centered on exactly this: helping sponsors understand not just what the Agency is asking, but why — and using that clarity to build programs that are more rigorous, more efficient, and ultimately more likely to reach patients.
That’s the perspective I’m bringing to this next chapter.
If you’re working on something in the oncology space and think this kind of drug development perspective could be useful, I’d love to connect.”
More at: Perspective That Shapes Programs From The Inside Out
Other articles featuring Nicole Gormley on OncoDaily.